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JMNI SCHOLARSHIP HONORS SHACKELFORD
The Washington University Medical Center
Alumni Association created the Distinguished
Alumni Scholarship Program (DASP) in 1989 to
annually provide first-year medical students with
four years of full-tutition funding. The scholarships
are named after distinguished alumni who are
Washington University faculty. A 1998 Distinguished Alumni Scholarship honors Gary Shackelford, MD, professor of radiology and of pediatrics.
The Shackelford Scholarship was awarded to
Hanna Wunsch, a 1997 Harvard University graduate
who began her medical training at Washington University School of Medicine in the fall of 1998.
Shackelford has been a member of the MIR
community since 1969 when he began three years of
diagnostic radiology residency and served as the
1971-1972 chief resident. He joined the Institute
faculty in 1972 as an instructor in radiology and was
later appointed professor of radiology (1982) and
professor of pediatrics (1983). An active participant
in student and resident education, Shackelford
served as director of Medical Student Education in
Radiology (1977-1981) and director of Diagnostic
Radiology Resident Training (1981-1988). He
received the 1995 Distinguished Teaching Award,
which is presented annually by the senior radiology
residents. He is a fellow of the American College of
Radiology and a member of the Radiological Society
of North America and the Society for Pediatric
Radiology (member of the Board of Directors, 1981
to 1983).
Other MIR faculty honored by DASP are (1995)
Barbara Monsees, MD, chief of breast imaging;
(1996) Ronald Evens, MD, director of the Institute;
and (1997) Barry Siegel, MD, director of the Division of Nuclear Medicine.
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NEW STUDIES YIELD RESULTS IN TREATING CERVICAL
CANCER
Based on five landmark research studies, the
National Cancer Institute reports that the survival
rate for women with advanced cervical cancer is
dramatically increased when chemotherapy is
added to standard radiation treatment.
VIRTUAL C0L0N0SC0PY, A 3-D VISUALIZATION OF
THE COLON
Researchers are evaluating a rapidly advancing
technology called spiral computed tomography
colonography to screen colorectal polyps, the precursors of colon cancer, by using two- and threedimensional images of the colon.
UTERINE ARTERY EMBOLIZATION: AN ALTERNATIVE
TO HYSTERECTOMY
The Washington University Comprehensive
Fibroid Center offers a nonsurgical alternative to
hysterectomy for women with uterine fibroids, the
most common benign tumors in women in the
United States.
THE ART OF IMAGING
Musculoskeletal radiologists are using the same
rapid prototyping technology that replicates a
patient's anatomy to assist in the The Saint Louis
Art Museum's restoration of an ancient Egyptian
mask.

SPOT NEWS
FYI

ON THE COVER:
According to the National Cancer Institute, colon cancer is a highly treatable
and often curable disease when detected early, yet it remains the second most
common cause of cancer death in the United States. Dr. Elizabeth McFarland
and a team of clinical and technical investigators are studying the reliability of
virtual colonoscopy, a promising method for screening colon cancer.
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NCI
establishes
clinical trials
network
Mallinckrodt Institute is
one of 42 institutions participating in a new cooperative
group committed to multicenter cancer-related clinical
trials. Established in
November 1998 and funded
by the National Cancer Institute, the American College of
Radiology Oncologic Imaging Network (ACRIN) is an
integrated collaboration
comprised of researchers
from radiology, other medical specialties, and related
basic and clinical sciences.
ACRIN's goal is to "improve
the health of cancer patients
through the advancement of
diagnostic imaging and
image-guided interventional
procedures."
Among its specific
objectives, ACRIN intends to
evaluate innovative diagnostic imaging and image-guided
treatment methods for cancer patients; reduce healthcare costs while improving
the effectiveness of patient
care; define and disseminate
standards of operation for
the high quality use of imaging technology; and, through
clinical trials, faciltiate the
early availability of new,
potentially valuable technologies to a broader range
of patients.
MIR faculty are active
members of ACRIN.
■ Jeffrey Brown, MD, associate professor of radiology,
director of clinical
research, and codirector
of magnetic resonance
imaging, is the Institute's
representative to ACRIN
and is a member of the
Receptor Imaging and
Delivery Systems
Committee.

i William Middleton, MD,
professor of radiology and
head of ultrasonography,
is a member of the Ultrasound Committee.

MIR faculty
among top
cancer doctors

David Piwnica-Worms,
MD, PhD, professor of
radiology and of molecular biology and pharmacology and director of the
molecular pharmacology
laboratory, chairs the
Receptor Imaging and
Delivery Systems Committee and is a member of the
Research Strategy Committee. He also is a member of the Basic Sciences
and Molecular Technologies Committee.

Good Housekeeping
magazine annually publishes
a listing of the "Top Cancer
Doctors" in the United
States. The magazine's
March 1999 issue narrowed
the field to feature those
doctors who "provide the
most expert treatment and
are the leading clinicians for
lung, breast, and colon cancer in women." The 318
physicians were those cited
most often in the 1,200 doctors nominated on surveys
sent to surgical, medical, and
radiation oncology department heads and section
chiefs at major U.S. medical
centers. Nominators could
not submit physicians from
their own institution.
Three MIR faculty were
among the experts:
■ Radiation oncology, colon
cancer—Robert Myerson,
MD, PhD, professor of
radiology.

Barry Siegel, MD, professor of radiology and of
medicine and director of
the Division of Nuclear
Medicine, chairs the
Nuclear Medicine/
SPECT/PET Committee
and is a member of the
Research Strategy
Committee.
Marilyn Siegel, MD, professor of radiology and of
pediatrics, chairs the Pediatrics Committee and is a
member of the Research
Strategy Committee.
Todd Wasserman, MD,
professor of radiology, is
chairman of the Radiation
Oncology Committee of
the Medical Specialties
Advisory Committee.

Jost chairs
RSNA
committee
Gilbert Jost, MD, director
of the Division of Diagnostic
Radiology, was elected to a
three-year term as chairman of
the Radiological Society of
North America's (RSNA) Electronic Communications Committee (ECC). Jost, who is a
professor of radiology and of
computer science, will guide
the ECC as it oversees RSNA's
initiatives to improve the
exchange of data among
radiology information and
imaging systems. The committee's 15 members are responsible for evaluating computer
software and hardware, magnetic and optical data, storage
devices, and electronic data
transmission.
"In order to efficiently
provide patients with optimal
care, physicians must be able
to retrieve data from many
sources, which requires the
complete integration of medical information systems,"
says Jost.
Under Jost's leadership,
the ECC will continue to promote enterprise-wide information sharing through an RSNA
program called Integrating the
Healthcare Enterprise (THE).
In partnership with the Healthcare Information and Management Systems Society, EHE is
working on a standards
process among systems that
will allow various elements of
a patient's medical history to
be incorporated into an easily
accessible record.

■ Radiation oncology, breast
cancer and lung cancer—
Carlos Perez, MD, professor of radiology and
director of the Radiation
Oncology Center.
■ Radiation oncology, breasi
cancer—Marie Taylor,
MD, instructor in radiology and chief of Breast
Cancer Service.
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MIR textbooks
included in
select list
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Since 1965, the
"Selected List of Books and
Journals for the Small Medical Library"—later called
the "Brandon List" for its
author and now the "Brandon/Hill List" to include its
coauthor—has been the
standard resource for hospital library collections.
Endorsed by the Joint Commission on Accreditation of
Healthcare Organizations,
the list contains the most
current and authoritative
information for the practicing clinician and serves as a
buying guide for health sciences librarians.
The list of journals and
textbooks appears biennially
in the Bulletin of the Medical Library Association
and has traditionally been
used as a planning tool for
developing or updating a
library print collection in a
hospital or facility involved
primarily in patient care. A
recent Brandon/Hill List
included two radiology textbooks authored or edited by
Mallinckrodt Institute
faculty.
Pitfalls, Variants, and
Artifacts in Body MR Imaging, authored by Scott
Mirowitz, MD, associate professor of radiology, radiologist-in-chief at Barnes-Jewish
Hospital north, and codirector of body magnetic resonance imaging, is a reference
of the wide range of MRI
artifacts and anatomic variants that can be mistaken for
pathology. Published in
1996, the book provides clincially relevant methodology
for making informed, accurate diagnoses.
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Evens leads
FPP Board

Pediatric Sonography,
now in its second edition,
was edited by Marilyn Siegel,
MD, professor of radiology
and of pediatrics. This comprehensive text on the pediatric applications of
sonography includes up-todate information on the grayscale and Doppler imaging
approach to a variety of diseases and the use of sonography in biopsy and
treatment. Book chapters
were authored by Siegel and
doctors Thomas Herman,
associate professor of radiology; William McAlister, professor of radiology and of
pediatrics and chief of pediatric radiology; Gary Shackelford, professor of radiology
and of pediatrics; William
Middleton, professor of
radiology and head of ultrasonography; and Marshall
Hicks, a former MIR faculty
member who is now head of
interventional radiology at
M.D. Anderson Cancer Center in Houston, Texas.

In January, Ronald
Evens, MD, director of
Mallinckrodt Institute, was
elected chairman of the 25member Board of Directors
of the Washington University
School of Medicine Faculty
Practice Plan (FPP). He succeeds Ralph Dacey, MD,
head of neurological surgery
and the Board's first
chairman.
With more than 800
physicians and clinical
revenues of more than $250
million, the full-time Washington University School of
Medicine (WUSM) physicians comprises one of the
largest consolidated multispecialty group practices in
the United States. The FPP
was initiated in 1997 to
revamp clinical care at
WUSM so that patients,
referring physicians, and
healthcare insurers would be
better served. The Practice
Plan Board is responsible for
managing the medical
school's clinical operations,
with specific responsibility
in the areas of clinical oversight, administration, fiscal
management, and clinical
planning.

"The establishment of
the Washington University
Faculty Practice Plan is a
direct result of the rapidly
changing healthcare market's effect on academic
medicine nationwide and
specifically in the St. Louis
region," says Evens. "The
FPP has already facilitated
significant advances in
strategic planning, medical
management, and financial
affairs, and we must continue to provide initiatives
that will efficiently re-engineer the way we practice
medicine."
Marilyn Siegel, professor of radiology and of pediatrics, was elected to a
second term on the Board
as a faculty-at-large representative. From the more
than 1,000 medical school
faculty, six representatives
are elected by full-time faculty within the clinical
departments.
Siegel's first two years
on the board were exciting
and productive. "The FPP
played an important leadership role in designing the
new ambulatory care center,
streamlining some patient
care activities, and planning
satellite facilities," she says.
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with advanced cervi-

cal cancer can now look to
chemotherapy to help fight their
disease. Researchers have found
that adding chemotherapy to the
standard radiation therapy dramatically increases a woman's survival
rate. Results from a series of five
landmark studies, all sponsored by
the National Cancer Institute during a seven-year period, are so significant that, for the first time in
four decades, changes are being
recommended in the treatment of
cervical cancer.

Results Li
Radiation Oncologist Perry Grigsby

Perry Grigsby, MD, MBA,
FACR, professor of radiology at
Mallinckrodt Institute, is a coauthor of two reports documenting
these study results; one of the
reports was published in the April
15th issue of The New England
Journal of Medicine. Because of
the potential impact on public
health, the Journal released the
study results on its web site prior
to the slated publication date, and
the NCI mailed a rare clinical
announcement to thousands of
physicians, notifying them of the
findings and urging them to consider the combination of
chemotherapy and radiation therapy for the treatment of invasive
cervical cancer.
The NCI recommends the combination treatment for women diagnosed with advanced cervical
cancer that has spread to the pelvic
lymph nodes or to the parametrium
(the connective tissue surrounding
the uterus) and for those who have
cancer cells in the tissues outside
of the removed tumor.
Radiation has been the treatment of choice for advanced cervical cancer since the 1950s. While
approximately 20 studies have
been done outside of the United
States using various combinations
of radiation and the chemotherapy
drugs hydroxyurea, cisplatin, and
5-fluorouracil, none showed a benefit. The five studies in the United
States, however, did show a benefit

using cisplatin and 5-fluorouracil in
tandem with radiation.
Grigsby attributes the difference in the study outcomes to the
drugs selected and to the strict
quality control guidelines of the
U.S. research. The guidelines
detailing the study are often 30 to
40 pages in length. "The research
that we do is conducted in a rigid,
scientific manner. It's important
research, and it's all done with taxpayers' dollars through the
National Cancer Institute," Grigsby
said.

STUDY RESULTS
Grigsby and scientists from the
University of Texas M.D. Anderson
Cancer Center, along with other
institutions and universities,
looked at the effects of adding
chemotherapy to radiotherapy. The
study included 403 women of all
ages who had advanced cervical
cancer with tumors that were too
large to remove surgically or with
cancer that had spread to pelvic
lymph nodes. Patients were randomly assigned treatment methods:
Some received external and internal radiation, others received
chemotherapy in addition to the
internal and external radiation.
For all patients, the radiation treatments were administered during an
approximate six-week period.
Externally, radiation was directed
at the pelvic area. Internally,

radioactive pellets were placed
temporarily in the vagina and
cervix. Those receiving chemotherapy had their first treatment within
16 hours of the first radiation treatment, with two more cycles of
chemo given at three-week intervals. The side effects were similar
for the women in the two groups;
however, women in the combined
therapy group had a higher rate of
blood-related problems, which
were reversible.
During treatment, patients
were evaluated weekly. After treatment, evaluations were done every
three months for the first two
years. In the third year, evaluations
were done every four months, then
every six months during the fourth
and fifth years.
After five years, the survival
rate for women receiving the combination of chemo and radiation
was 73 percent. Those women who
received only radiation had a 58
percent survival rate. While these
findings were encouraging, women
in the combination therapy group
could still have the disease. Taking
the statistics a step further, 67 percent of the women who had
received the combination treatment
did not have cervical cancer after
five years, while 40 percent of
women in the radiotherapy group
had beat the disease.
Following the study,
researchers found that adding
chemotherapy reduced the chances

Treating Cervical Cancer

by Chris Wayland
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New Studies Yield Results

for recurrence of cervical cancer.
This study also differed from others in that the median dose of radiation was higher and the median
duration of treatment was shorter.
A more aggressive regimen of
chemotherapy was used with three
cycles, administering a higher dose
of cisplatin than the dose of fluorouracil used in other studies.

Because of the potential impact on public
health, the Journal
released the study
results on its web site
prior to the slated
publication date...
These volumetric images, produced from raw CT
scans, reconstructed CT data, and digitally recon-

I
.

According to Grigsby, while
the findings are significant, some
women in the study were hesitant
to undergo the chemotherapy.
"Some patients said that if there
was a chance she would receive
chemotherapy, then she wouldn't
participate in the study," he says.
"They knew a relative or a friend
who had undergone chemo and
hadn't done well. Even though
women knew that their survival
rates might increase with the combined therapy, there was still some
hesitancy."

structed radiographs, show axial, sagittal, and coronal views of the uterus, cervix, and tumor. Radiation
oncology physicist Dr. Jeffrey Williamson received an
NCI grant to study the treatment of locally advanced
cervical cancer through an integration of imaging
techniques.

In a second study, chemotherapy and radiation were given to
women with invasive cervical cancer who had already undergone
radical hysterectomies and lymphadenectomies. In those cases,
the cancer had spread to pelvic
lymph nodes, to the tissue surrounding the tumor, or to the parametrium. The survival rate for the
268 patients participating was 63
percent after four years.
"The findings from this study
[which were presented in March
to the Society of Gynecologic
Oncologists in San Francisco]
also showed a significant benefit to
adding chemotherapy to the radiation therapy," Grigsby says.

The three remaining studies
were similar in that radiation was
compared with the chemotherapy
drugs cisplatin, 5-fluorouracil, and
hydroxyurea, and all of the studies
found the addition of chemo to be
beneficial. The studies were performed by three of the NCI's Clinical Trials Cooperative groups,
comprised of institutions and
physicians that conduct trials
jointly.
In these studies, chemotherapy
and radiation were given simultaneously—according to information
from previous, smaller NCI studies,
the treatments were found to have
a greater effect when administered
together than if given one after the
other. Researchers believe that
chemotherapy makes cells more
receptive to radiation or vice versa
Chemotherapy also may prevent
cancer cells from repairing the
damage caused by radiation.
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CAUSE AND EFFECT
Stopping the cancer cells
becomes even more imperative
when you look at the statistics:
Cervical cancer is the most common type of cancer in women
worldwide. In 1998 in the United
States, an estimated 13,700 women
were diagnosed with invasive cervical cancer. Of those, nearly 5,000
will die from the disease. According to the National Institutes of
Health, half of the women with
newly diagnosed invasive cervical
cancer have never had a Pap test—
the standard screening test for
abnormalities. Another 10 percent
have not had a Pap test in the past
five years. Most at risk are minorities and low-income women who

have insufficient access to and
knowledge of the screening. The
disease can be detected and treated
early, with early detections tested
and rated using a standardized
scale. It is only after the disease
has been undetected, often over
the course of several years, that it
becomes invasive.
Pap tests are recommended
when women become sexually
active or at age 18. Generally the
tests are done once a year, but if
any abnormalities are detected,
Pap tests are recommended more
frequently.

At the root of most cervical
cancer—93 percent—lies the
human papillomavirus, known as
HPV. More than 70 types of HPV
have been identified; twenty-three
of them infect the cervix, according to information from the
National Institutes of Health. Only
some of them are associated with
invasive cervical cancer. The virus
is transmitted through sexual
intercourse, and infection is most
prevalent in women ages 22 to 25.
Infection decreases with age, suggesting that most are resolved
through host immune responses.
"HPV is sexually transmitted,
and it's clearly a cause of cervical
cancer. But we don't know if all
cervical cancers are caused by
HPV," Grigsby says.
In theory, cervical cancer can
be prevented, and education is the
key. Young women must learn
how cervical cancer can be transmitted. Throughout their lifetime,
women—and this includes postmenopausal women—must continue to have regualr Pap tests.
Worldwide research for an HPV
vaccine has begun, and planning is
underway at the NCI for a vaccine
to be used as an auxiliary treatment after radiation or chemotherapy. Other vaccines focus on
prevention. Early reports from an
NCI study showed that a vaccine
stimulated the body to produce
antibodies to HPV. Further studies
are being done, and if they are
promising, the vaccine will be
tested in larger numbers of
women. ETJH
Chris Wayland is a St. Louisbased free-lance writer.
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BY KIRSTIN BLASE

iolon cancer remains the second leading cause of cancer death in the
United States, but a rapidly advancing technology may help to reduce that
statistic through the early detection of colorectal polyps, the precursors of
colon cancer. Spiral computed tomography (CT) colonography—or virtual
colonoscopy—provides a noninvasive evaluation of the colon, using both
two- and three-dimensional visualization displays.
Elizabeth McFarland, MD, assistant professor of radiology at Mallinckrodt Institute, has received a $500,000 contract from the National Cancer
(Large background
image) Two centimeter

Institute (NCI) to study the diagnostic performance of this evolving tech-

sigmoid polyp with 3-D
endoscopic visualization
with spiral CT. (This

nology. Along with the 3-D visualization of the entire colon, spiral CT

image is from Dr.
McFarland's scientific

colonography also views colorectal polyps from a variety of angles, using a

paper "Evaluation of
processing parameters
with perspective volume

spectrum of 2-D and 3-D image display techniques.

rendering" published in
a 1997 issue of the
journal Radiology, vol-

This diagnostic breakthrough enables doctors to virtually maneuver

ume 205, pages 701707.)

through the colon by using a 3-D software package called Vitrea, which was

Nine millimeter polyp in

developed by Vital Images, Inc. of Minneapolis. With the patient's obvious

rectosigmoid (arrow)
displayed with spiral CT,
using

benefit from a noninvasive procedure and the physician's diagnostic advan-

(A) axial 2-D multiplanar reformation (MPR)
(B) sagittal 2-D MPR

tages, spiral CT colonography has shown promising results in the initial

(C) 3-D endoscopic CT

clinical studies.
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COLONOSCOPY

Colorectal cancers are the third
most frequently occurring cancers among men and women in the
United States. There are approximately 160,000 new cases each year
that result in 60,000 deaths and billions of dollars in costs. At all ages,
men are more likely to develop colorectal cancer than women. African
Americans have higher colorectal
cancer incidence and mortality rates
than men and women of other racial
and ethnic groups. These staggering
statistics reinforce the need for
detection of early lesions and precancerous polyps in the colon.
"In the United States, there is a
need for accurate, noninvasive, total
colonic screening for colon cancer.
Virtual colonoscopy may fill this
need," says Leonard Weinstock, MD,
a coinvestigator of the research and
an associate professor of clinical
medicine in the Division of Gastroenterology.

With virtual colonoscopy, the
patient is positioned on the
bed of a spiral CT scanner. After
the bowel is prepped, air is introduced into the colon through a
small tube. Operating on a slip-ring
technology, spiral CT allows the bed
on which the patient is lying to
move through the gantry at a steady
pace while the X-ray beam traces a
360-degree spiral pathway around
the patient. The patient is in the
scanner for less than 30 minutes.
Scans are taken—one while the
patient is facedown; one, faceup—
while the patient inhales, maintains
a 40-second breathhold, and
exhales. After the images are completed, the air in the distended
colon is removed through another
small tube. Patients may experience some minimal discomfort from
cramping caused by the insufflation
of air and distended colon.
The CT images are then electronically transferred to a dedicated

3-D workstation. Using the Vitrea
software, these images are converted into a three-dimensional volume that is developed from
approximately 200 CT slices, each
about two millimeters thick. Multiple 3-D rendering algorithms are
applied to automatically create a
variety of interactive 2-D and 3-D
visualizations. In general, a radiologist can use the two-dimensional
multiplanar reformations simultaneously to cross-reference a focal finding in the axial, sagittal, and coronal
planes. This provides not only a
quick survey of the colon but the
ability to interactively "fly" into the
McFarland and the technical team in the Institute's Electronic Radiology Laboratory (ERL): (left to right) Bruce
Whiting, PhD; Thomas Pilgram, PhD; Barry Brunsden,
research engineer; and Paul Koppel, PhD. Not shown is
James Blaine, DSc, director of the ERL Whiting constructed this phantom of a colon containing different
sizes and shapes of polyps so the team could better
study the rippling artifacts that can occur in spiral CT
imaging.
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3-D endoscopic view. The simultaneously displayed intraluminal and
extraluminal images also allow the
radiologist to maintain orientation
along the course of the colon.
In early clinical trials, virtual
colonoscopy has detected 67 to 83
percent of polyps that are one centimeter or larger in size. In a multiobserver study to assess the
diagnostic performance of spiral CT
I id to evaluate the radiologists'
terpretations, doctors Jay Heiken,
, ofessor of radiology and codirec- of body computed tomography;
nnis Balfe, professor of radiol*y; and James Brink, vice-chairlan of the Department of
Jadiology at Yale University, compared results from a spiral CT test
set of colonic segments to those
achieved with colonoscopy, the
gold standard for detecting colorectal polyps. With both 2-D and 3-D
display techniques, CT's overall sensitivity to detect polyps ranged from
83 to 92 percent. Heiken, Balfe, and
Brink also reread the cases in a second session, and both intra- and
inter-observer agreement were very
good. MIR investigators also are
collaborating with Ge Wang, PhD,
of the University of Iowa, on a new
display technique to "unravel" the
colon.

ners. "With this approach, a better
understanding of the image formation process will result in improved
diagnostic information," says
Whiting.
Systems costs is a major consideration in the acceptance of virtual colonoscopy by the general
community. In the early phases of
the studies, the UNIX-based systems for the silicon graphics-level
computers cost arround $200,000.
Currently, a UNIX-based system
called 02 is considerably less
expensive at approximately $20,000.
"The competitive pressures are
such that all vendors, all different
software companies, are pushing
this into an NT environment, a
desktop environment," says McFarland. "The computer graphics that
enable this type of visualization are
pushed by a demand for threedimensional visualization. Further
competition will make this workstation more affordable in coming
years."

Spiral CT colonography, as is true
of most new medical procedures,
will go through varying stages of
development. The study is now in
the second stage of technology
assessment: the evaluation of
reader performance among expert
readers compared to conventional
colonoscopy performance. Following optimization and standardization of numerous parameters of
both image acquisition and rendering, performance of this technique
among expert radiologists first
needs to be determined. The diagnostic performance of spiral CT in
generalized settings will then be the
next stage.
The Mallinckrodt Institute contract is part of a larger Washington
University grant coordinated by
Principal Investigator Gerald Andriole, MD, who is head of a preventive cancer research organization
called PLCO (an acronym for
prostate, lung, colon, and ovary).

Multiple issues of the rapid spiral
CT acquisition are under investigation, including the occurrence
of rippling artifacts that can
degrade the image quality. Bruce
Whiting, PhD, of the Institute's Electronic Radiology Laboratory, developed specific quantitative metrics
to evaluate the influences of CT
acqusition parameters, such as
pitch and angle, on the frequency
and magnitude of the artifact. This
approach is being used to analyze
the performance of a new generation of multirow detector CT scanThe clinical team: Clinical coordinator Mary Virginia
Gaines; Leonard Weinstock, MD, (left); and Jay Heiken,
MD. Not shown is Benjamin Littenburg, MD.
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COLONOSCOPY

Currently, McFarland's study is
recruiting 70 patients with colorectal polyps who also meet the criteria of Andriole's PLCO study. At
this point, the CT exam is in the
validation stages and is not avail-

In early clinical trials,
virtual colonoscopy
has detected 67 to 83
percent of polyps that
are one centimeter or
larger in size.
able as a routine test. If results
continue to be promising, the next
stage will be technology assessment of spiral CT in the general
community.
Virtual colonoscopy is definitely a product of a constantly
expanding computer age. The transition of two-dimensional CT slices
into a three-dimensional image of
the colon has entailed a multitude
of expertise. As McFarland points
out, "This technology will require a
very strong multidisciplinary cooperative effort where radiology, gastroenterology, computer science,
and electrical engineering work
very closely together."
With decreasing workstation
costs and additional applications
for the procedure, such as the trachea, the possibilities of this technology reaching the general
community is increasing. It's virtually there, cm
Editor's note: Dr. McFarland's spiral
CT colonography research has also
been generously funded by a two-year,
General Electric-Association of University Radiologists career grant and
by grants from the Barnes-Jewish
Hospital and Washington University
Cancer Center.
12

RISK FACTORS
I

FOR COLORECTAL CANCER

Age—Older age is the single most important risk factor for the development of colorectal cancer.

i Familial factors—A personal history of colon cancer, intestinal adenomatous polyps, or inflammatory
bowel disease also increase a person's likelihood of
developing colorectal cancer.
i Diet—A diet high in animal fats(i.e., red meats) is
thought to increase the risk for developing colorectal
cancer while a diet high in vegetables and fruits is
considered protective.
Physical activity—Participation in regular physical
activity may reduce a person's risk for developing
colon cancer. Obesity has been shown to increase the
risk for colon cancer in men.
Hormone replacement therapy—Current use of
hormone replacement therapy may decrease the risk
for developing colorectal cancer in postmenopausal
women.
Aspirin use—Men and women who use nonsteroidal
anti-inflammatory drugs may have a decreased risk for
developing colon cancer and other cancers of the
digestive tract.
This information was excerpted from the American Cancer Society's 1999
Facts & Figures.

VIRTUAL COLONOSCOPY
MALLINCKRODT INSTITUTE OFRADIOLOG
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UTERINE ARTERY EMBOLIZ ATION:

AN ALTERNATIVE

TO HYSTERECTOMY

Tyi-any women with uterine fibroids have discovered a third treatment option: a relatively new
lVlnonsurgical procedure called uterine artery embolization. The concept was develonedTn
France in the ear y 1990s and has been adopted worldwide for the treatmento7more IhaTl OoS
women with excellent clinical and therapeutic results. In the United States, it Sperfo^edZtindy
at an mcreasing number of medical facilities, including Washington University MedicXnter
m St common beni n tum
t
£ ? * 1^
°
g
ors in women in the United States todav ' From
lZT°'TPeTnt °f W°men ^ flbr°idS "*> aMrou«h 0^y a ^* °f the tumorsSe wZ
tomato, millions of women continue to live with them because the only alternative is surgery X
me artery embolization has the potential to transform how fibroids are treated ^SS'rkm*
Institute of Radiology's David Hovsepian, MD, assistant professor of ZSo^L Xr^*"*
gist a^d VaS:^Rafts'anH Th" ^--doctors S—* Vedantham, afinterventionafradiologist, and Valerie Ratts and Thomas Herzog, gynecologists—founded the Washington Universitv
Comprehensive Fibroid Center to treat women with this common problem b^SZg exceUent
care and acquainting them with all of their treatment options
Providing excellent
Since June 1998, Hovsepian himself has treated seven women with uterine artery embolizatinr,
and has more cases scheduled. Several women have found him via the IntemetTJr^TabZ

soSc^r m magaZin6S °r neWSPaPerS'

H VSepian 1S impressed b

°

^ httatients^eS

"These women are highly motivated and well-educated," he says. "They have usually been told
SE^SST^' S° ^ * ^ ** ^ d° — -eLive hoTetoil^nd
PROCEDURAL BACKGROUND
Uterine fibroids-or leiomyomata-are benign growths that arise from the muscular wall of the
uterus. In some women, they can cause excessive menstrual bleeding, pain, LTa fee^of heavt
ness in the abdomen. In fact, they may
grow so large that a woman appears to be
in an advanced state of pregnancy.
Fibroids also may exert pressure on the
bladder and lead to voiding problems and
even incontinence.
Traditionally, a hysterectomy has been
the recommended treatment, particularly
for older women who are not concerned
about preserving their fertility. In 1995, for
example, some 600,000 women underwent a hysterectomy, making it the most
commonly performed surgical procedure
in women in the U.S. One-third of those
procedures was for the treatment of uterine fibroids.
Myomectomy, which spares the
uterus, is an alternative to hysterectomy,
especially for younger women who may
later wish to become pregnant. It is a
more time-consuming procedure than a
standard hysterectomy, even longer if the
procedure is done laparoscopically, since
the physicians painstakingly remove the

Intervention^ Radiologist David Hovsepian
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The cluster of two small circles and one square on each of the three images represents a dosimetry badge that monitors the amount of radiation.
1. Pre-embolization arteriogram shows prominent left and right uterine arteries (arrows) due to high blood flow. 2. Selective injection of left
uterine artery shows a large fibroid (area within arrows). 3. Postembolization arteriogram shows no filling of uterine artery, but all other pelvic
branches have normal blood flow. The dense area is the bladder (arrow), which has filled with contrast from the procedure.

individual fibroids. Not only does myomectomy carry the risks of any surgical procedure, there
are other disadvantages as well: Small fibroids may be left behind only to enlarge later, or brand
new fibroids may grow. Most frustrating of all is the chance that the key fibroid, which is causing
most of the problems, may be left untreated.
In the early 1990s, a French physician, Jacques Ravina, conducted a study of women awaiting
myomectomies. To reduce blood loss during surgery, Ravina and his colleagues embolized the
patients' fibroids preoperatively. The results were surprising. The fibroids shrank, and the bleeding stopped. Many women were so pleased with the results that they canceled their planned
surgery. To verify these findings, the investigators conducted a multicenter trial and had the same
results.
Physicians at the University of California, Los Angeles (UCLA) learned of the French group's
published reports and, in 1996, began their own study of uterine artery embolization. In the initial
experience at UCLA, 11 women who had failed medical or surgical therapy underwent embolization. Out of nine women who completed the postoperative questionnaire, eight experienced
symptomatic relief; only the ninth woman required a hysterectomy because of an infection. Thus,
the technical success and the symptomatic improvement rate were very high.
When Hovsepian saw a presentation of the UCLA data, he was fascinated by this procedure, a
fascination fed by his clinical interest in gynecologic interventional radiology—especially methods
for treating fallopian tube occlusion and possible ways to achieve reversible tubal sterilization—
and for treating pelvic venous congestion syndrome, a poorly understood and underrecognized
condition in women who suffer from debilitating pelvic pain and pressure.
"In truth, uterine artery embolization is not a new technology. It is a new application of existing techniques," he says. "For years, many women have only been given the option of a hysterectomy for treatment of their fibroids, which has meant the loss of being able to bear children.
Embolization for fibroids has the potential for helping a lot of women."
THE MIR TECHNIQUE
If a patient refers herself to Hovsepian and has not been seen recently by a gynecologist, Hovsepian first refers her to the gynecologists on his team for a physical exam and lab tests to rule out
other reasons for her symptoms and to discuss the surgical options. Those patients who are still
interested in having the embolization then meet with Hovsepian and clinical coordinator Pat Norton, RN, to discuss what the patient should expect before, during, and after the procedure.
On the day of the embolization, the patient checks in to the hospital early in the morning to
undergo any remaining tests. She is instructed not to eat any food after midnight preceding the
morning of the embolization. The procedure requires intravenous sedation only, not general anesthesia, so the recovery period is short and without side effects.
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The secret to the success of embolization, says Hovsepian, is that fibroids are highly vascular
and dependent on blood supplied by the left and right uterine arteries. In the arteriogram, taken at
the beginning of each procedure, these arteries are very visible. Engorged with blood, they become
enlarged and take an easily recognizable course to the uterus.
The objective of the procedure, which can take from one to three hours, is to block the blood
flow through these arteries. It is necessary to embolize both arteries, Hovsepian stresses. Previous
experience in which only one artery was blocked resulted in failure.
Through a small incision in the patient's groin, physicians insert a tiny plastic tube, or catheter,
which is guided into each uterine artery—one after the other—using the arteriogram as a map.
Once the catheter is in place, 350 to 500 micron-size particles of polyvinyl alcohol (the size of grains
of sand) are injected through the catheter. These granules immediatley block the arteries, obstructing blood flow to the fibroids.
"In most of these cases, as soon as the fibroids have been embolized, the patient feels crampy
abdominal pain, sometimes accompanied by nausea and vomiting—called 'post-embolization syndrome'—that lessens over the next few days," says Hovsepian. "It is usually necessary for the
patient to stay overnight in the hospital so that she can be given strong medicines to provide optimum pain control."
During the procedure, the patient receives intravenous medication for pain and relaxation;
afterwards, she is placed on a morphine patient-controlled analgesia (PCA) pump, so that she can
determine her own need for pain relief. Gradually, the patient is switched to oral medicines.
Ibuprofen and Tylenol® are also added to treat the soreness and fever that usually develop during
the first few days after embolization as the fibroids begin to break down. By the third or fourth day
after the procedure, the patient can usually return to a modified routine, with most women returning to work within a week.
All of the fibroids are treated at the same time, and as they have been starved for oxygen or
nutrients, they begin to shrink. Some fibroids "melt" away entirely, and occasionally some which
have grown on a stalk inside the uterine cavity may even be expelled. A follow-up ultrasound at six
months shows that, on average, the fibroids have diminished in size by 40 to 50 percent.
"If you combine all of the available reports," says Hovsepian, "approximately ninety-two percent of patients have sufficient symptomatic relief from either pain or bleeding so that no further
treatment is necessary."
A fter undergoing uterine artery embolization, a few women in their forties stopped having
X\periods. It is still unclear whether or not embolization effected the early onset of menopause
for these women or whether they were already perimenopausal, a fact which became evident only
after the abnormal bleeding had disappeared.
Therefore, until embolization's possible effect on fertility is determined, younger women who
want to have children are being counseled to consider myomectomy, unless it is not feasible,
instead of embolization. No negative impact from embolization has been found. In fact, in a group
of 25 women who had uterine artery embolization for postpartum hemorrhage, each of the six
patients who tried to become pregnant afterwards succeeded.
"We explain all of this in detail to patients before the procedure so that they can understand the
potential risks and benefits and can make their own informed decisions," Hovsepian adds.
Hovsepian and his colleagues have constructed a database to track information on patients,
their risk factors, fibroids, and ultrasound findings. A multicenter trial is in the planning stages to
thoroughly evaluate the results of this procedure and to compare it with the current gold standard,
myomectomy. There are a number of questions that remain unanswered, such as who will and who
won't benefit from this procedure, but for now, he says, "Uterine artery embolization has the potential for helping a large number of women."
Editor's note: For more information, visit the Comprehensive Fibroid Center's web site at
www.mir.wustLedii/fibroid.
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ONE WOMAN'S CRUSADE

Gail Hudson's uterine artery embolization was the most difficult—and longest—of any performed by interventional radiologist David Hovsepian. But Hudson, a St. Louis resident, is
still an ardent fan. In fact, Hovsepian calls her a "one-woman crusade" for the procedure.
In a routine examination some 15 years ago, Hudson's physician found a fibroid mass the size
of a grape. Over the years the mass grew much larger, finally to the size of a cantaloupe. But Hudson didn't have many symptoms, except heavier than normal menstrual periods and an increasingly
distended abdomen.
"Then I started to get indigestion and heartburn," she says. "The bulk of the growth had begun
to push up over my navel. That's when I decided that I had been 'pregnant' with this long enough."
After she read a short piece in a magazine about uterine artery embolization, Hudson, a software systems engineer, went to the Internet to learn everything she could about the procedure.
Impressed by what she found, Hudson decided to undergo the embolization—but where? At first,
she considered flying to Los Angeles where doctors were performing the procedure, but then she

{

found Hovsepian's name on the Internet and decided she could get the same treatment much closer
to home.
In October 1998, Hudson had the procedure, which took longer than usual—a full three hours.
After surgery, she seemed to have bypassed the typical crampy pain; two days later it hit, with pain,

t'rm

dizziness, and vomiting. Gradually, Hudson felt better and two weeks later went back to work.
Now her uterine mass is down to the size of a tennis ball, and the abnormal bleeding has stopped.
Hudson was pleased with the "awesome" care she received from Hovsepian, who was compassionate and concerned throughout her treatment. She was so delighted with the results of the procedure that she wants to let other women know about it and has even invited Hovsepian to speak to
a group of her coworkers about the procedure.
"It seems as though everyone you talk to knows someone with fibroids or is in the situation
herself. Hopefully, we will get the word out to them that there is an alternative to surgery," she
says, ima
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"^here's a fine line between art and
science, and that connection is
especially apparent in a research
project of radiologists Douglas Robertson
and William Totty and senior research
engineer Kirk Smith. Using their expertise
in computed tomography (CT) and rapid
prototyping technology, the Mallinckrodt
Institute team is collaborating with The
Saint Louis Art Museum in the restoration
of an ancient Egyptian mummy mask.
The funerary mask, which may have
belonged to a noblewoman who lived
around 1250 BC, during the time of Ramses the Great, provides a rare opportunity to research materials and artists'
techniques used during the height of
Egypt's artistic achievements. Due to the
mask's fragility, the Art Museum conservators needed a means to objectively
study the damaged areas of the mask and
plan the repairs without causing additional
harm to the artifact.
For the past three years, Robertson,
an assistant professor of radiology and of
orthopaedic surgery, has been studying a
new rapid prototyping technology that
uses patient data gathered from computed
tomography or magnetic resonance imaging to create detailed copies of the
patient's anatomy. Funded in part by a
Whitaker Biomedical Foundation grant and
working with Stratasys, Inc., the Minnesota-based company who developed the
rapid prototyping software, Robertson is
evaluating the technology for its use in
producing three-dimensional models to aid
in the preplanning of hip joint replacement
surgery.

I. Conservator Suzanne Hargrove shows William
Totty, MD, (leit) and Douglas Robertson, MD, PhD,
the progress on repair of the diadem and portions of
the hair.
2. The model, made of layers of nontoxic wax or
plastic, replicates the damaged areas of the original
mask, which was formed by layers of thin linen, plaster, and wood.
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Robertson is eager to test other
applications for the rapid prototyping
equipment, and the museum project provided a rare opportunity. Because the
mask has no water content and is comparable in value to bone, Totty, who is a
professor of radiology specializing in musculoskeletal imaging, used computed
tomography (CT) to produce images comprised of 500 slices, each one millimeter
thick. Working after hours so there would
be no disruption in the scheduling of
patients, the research team then converted
the CT data to computer-aided design
(CAD) descriptions that would be channeled to computer-controlled modeling
equipment.
A large hole on the top portion of the
mask's head required extensive repair. In
order to protect the mask from excessive
handling, the actual repairs were to be
made on a one-to-one ratio model. The
repair would then be lifted from the model
and placed directly onto the corresponding

^^■^^

3 & 4. Suzanne Hargrove (above with Dr. Totty and
below with Kirk Smith) is attempting to match the
damaged bitumen hair or wig portions of the mask.
Bitumen is a hydrocarbon, such as asphalt or tar,
that was used in ancient Asia Minor as a cement or
mortar and as a waterproofing agent.
(Round inset, interior view) The model identifies
cracks and weakened portions of the actual mask.
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area of the mask. The rapid prototyping
equipment housed in Mallinckrodt Institute's Musculoskeleta! Modeling and Visualization Laboratory is limited to a 10-inch
cubic volume and could not replicate the
mask's approximately 21-inch size. So
the CAD data was transmitted to Stratasys' headquarters, where commercial
modeling equipment has been used to produce models as large as car engines used
in automobile industry research.
The resulting mask model was a
resounding success. "We were pleased
that the full-scale model picked up so much
detail and were excited to be a part of
this important project," says Robertson.
"The link between human history and scientific technology is invaluable for all generations."
Back at the museum, objects conservator Suzanne Hargrove is using the
model twin to meticulously reconstruct the
original mask's damaged areas. The
restored mask is scheduled to be part of a
mask exhibit at The Art Museum this fall. ™»
5. The face was originally fashioned from a gold foil,
which has oxidized over the years to a deep red
color. Gold on the face of a burial mask was
reserved for high-ranking individuals. The eyes, eyebrow, and eyeliner are made of inlaid glass, which at
the time was considered as valuable as gems.
6. The diadem encircling the top portion of the head
is highlighted with gilding and is comprised of glass
inlays.
(Round inset) The scene on the bottom chest portion
of the mask depicts the deceased's entrance into the
afterlife where she is met by Osiris, god of the
underworld.
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FYI
In this section, the names of personnel who are full-time faculty
or staff or who have an appointment in the Department of
Radiology are highlighted in boldface type.

THE DIRECTOR'S
OFFICE REPORT
OFF STAFF
Joseph Borrello, MD,
assistant professor of radiology, Division of Diagnostic
Radiology, has accepted a
position with Kalamazoo
Radiology, P.C., in Kalamazoo, Michigan.
Andrew Fisher, MD, assistant professor of radiology,
Division of Diagnostic Radiology, has accepted a position with Radiology Imaging
Associates in Englewood,
Colorado.

Lorraine Portelance, MD,
instructor in radiology, Radiation Oncology Center, completed a one-year fellowship
in radiation oncology and
has accepted a position with
the Work Centre Hospitalier
Regional de l'Outaouais in
Gatineau, Quebec, Canada.
Rao Vallabhaneni, PhD,
instructor in radiology,
Division of Radiological
Sciences.
Myeong Yoon, MD, instructor in radiology, completed
four years of training in diagnostic radiology and a sixmonth fellowship in breast
imaging. She has accepted a
position with Radiology
Associates of Pensacola in
Pensacola, Florida.

HONORS/
AWARDS
Jay Heiken, MD, professor
of radiology, chief of abdominal radiology, and codirector of body computed
tomography, was selected as
the 1999 Traveling Fellow of
the Society of Gastrointestinal Radiologists.
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GRANTS
Clifford Chao, MD, assistant professor of radiology,
as principal investigator,
received a one-year BarnesJewish Hospital Cancer
Research Award to study
"The impact of tumor
hypoxia/reoxygenation
kinetics on radiation curability in head and neck cancers." Coinvestigators for
the $30,000 grant are Walter
Bosch, DSc, instructor in
radiology; Duffy Cutler,
PhD, assistant professor of
radiology; Farrokh
Dehdashti, MD, associate
professor of radiology;
Barry Siegel, MD, professor of radiology and of medicine and director of the
Division of Nuclear Medicine; and Michael Welch,
PhD, professor of radiology
and of chemistry and codirector of the Division of
Radiological Sciences.
Thomas Conturo, MD,
PhD, assistant professor of
radiology and adjunct assistant professor of physics, as
principal investigator,
received a National Institutes of Health/National
Institute of Neurological Disorders and Stroke grant in
the amount of $2,024,851 for
research on "MR perfusion
imaging for functional brain
studies." Coinvestigators for
the five-year grant are Erbil
Akbudak, PhD, research
instructor in radiology;
Joanne Markham, MS,
research associate, Institute
of Biomedical Computing,
and research assistant professor of medicine, Washington University; Abraham
Snyder, PhD, MD, research
scientist of radiology; and
Mark Mintun, MD, associate professor of radiology.

Elizabeth McFarland, MD,
assistant professor of radiology, as principal investigator, received a two-year
March of Dimes Birth
Defects Foundation grant for I
research on "MRI evaluation
of soft palate motion during
speech: comparison between |
cleft palate patients." Peter
Witt, MD, assistant professor |
of surgery (plastic and
reconstructive), Washington
University, is coinvestigator
for the $87,000 grant.
Joseph Roti Roti, PhD,
professor of radiology, associate director of the Radiation Oncology Center, and
chief of cancer biology, as
principal investigator,
received a one-year renewal
grant from the National
Institutes of Health for
research on "Nuclear-protein
content and heat-induced
ceh killing." Coinvestigator
for the $223,585 grant, now
in its thirteenth year, is
Ryuji Higashikubo, PhD,
research assistant professor
of radiology.
Weili Lin, PhD, assistant
professor of radiology, as
principal investigator,
received a $1.2 million giant
from the National Institutes
of Health/National Instil ute
of Neurological Disorders
and Stroke for the stud\ of
"Quantitative brain oxiiuetry
using MRI." Coinvestigators j
for the four-year grant are
Mark Haacke, PhD, profes |
sor of radiology and of electrical engineering and
director of the magnetic resonance imaging researc
laboratory; William Po^ ers, MD, associate professor of neurology and
neurological surgery an if
radiology; and Chung H
MD, professor of neurol ■>'.
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TOINTMENTS/
SECTIONS
Jeffrey Bradley, MD,
„.structor in radiology, was
appointed associate director
of clinical curriculum for the
Radiation Oncology Center
Residency Training Program
at Mallinckrodt Institute.
Jay Heiken, MD, professor
Df radiology, chief of abdomnal radiology, and codirec• of body computed
tomography, was appointed
i the 1999 Radiological
Society of North America
I Scientific Assembly and
Annual Meeting Program
Committee, Gastrointestinal
Subcommittee.
Jeff Michalski, MD, assisnt professor of radiology,
vas appointed to associate
Imembership in the TnterI group Rhabdomyosarcoma
I Study Group, an affiliate of
the Children's Cancer Group
and Pediatric Oncology
jroup.

Scott Mirowitz, MD, associate professor of radiology,
radiologist-in-chief at
: Barnes-Jewish Hospital
north, and codirector of
body magnetic resonance
imaging, was named a Diplomate of the American College of Physician Executives.
He was appointed to the
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American Roentgen Ray
Society's (ARRS) Instructional Committee as coordinator of the Socioeconomic
Track for ARRS' 2000 Annual
Meeting.
Joseph Roti Roti, PhD,
professor of radiology, associate director of the Radiation Oncology Center, and
chief of cancer biology, was
appointed to a one-year term
as councillor of the North
American Hyperthermia
Society and was appointed
to the International Organizing Committee of the Cell
Stress Society.
Barry Siegel, MD, professor of radiology and of medicine and director of the
Division of Nuclear Medicine, was appointed chairman of the Diagnostic
Radiology Committee of the
American College of Surgeons Oncology Group.

Senturia Lecture
Thomas Spackman, MD, chairman of Xicon Technologies and former president and CEO of Elscint,
Inc., presented the Fifth Annual Hyman R. Senturia
Lecture on February 8 in MIR's Scarpellino Auditorium. Dr. Spackman, who also is a clinical professor
of radiology at the University of Connecticut, spoke
on "Watching radiology by an occasional radiologist."

Pamela Woodard, MD,
assistant professor of radiology, was appointed to the
editorial board of Current
Protocols in MRI, a quarterly
reference guide. Mark
Haacke, PhD, professor of
radiology and of electrical
engineering and director of
the magnetic resonance
imaging research laboratory,
is editor, and Weili Lin,
PhD, assistant professor of
radiology, is associate editor.
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LECTURES/
PRESENTATIONS
DeWitte Cross, MD, assistant professor of radiology,
as invited lecturer, presented a seminar on "Management of posterior
circulation aneurysms" and
"Clinical response to intraarterial papaverine for cerebral vasoplasm" at the
American Association of
Neurological Surgeons and
Congress of Neurological
Surgeons Joint Section on
Cerebrovascular Disease
and American Society of
Interventional and Therapeutic Neuroradiology Meeting, Nashville, Tennessee,
January 31 - February 3.
Duffy Cutler, PhD, assistant professor of radiology,
as invited lecturer, spoke on
"Whole body PET: 2D or
3D?" at the Society of
Nuclear Medicine Mid-Winter Symposium, Fort Lauderdale, Florida, February 8
and 9.

Colin Derdeyn, MD, assistant professor of radiology,
presented "A cost-effective
analysis of therapy for symptomatic carotid occlusion:
PET screening followed by
selective EC/IC bypass versus medical treatment" and
"Benign course of asymptomatic carotid occlusion" at
the 24th International Joint
Conference on Stroke and
Cerebral Circulation,
Nashville, Tennessee, February 4. He spoke on "Carotid
disease and stroke" and
"Acute stroke intervention"
at the Current Concepts in
Peripheral Vascular Disease
Symposium, NorthEast Medical Center, Concord, North
Carolina, February 16.
David Diamond, MD, assistant in radiology and cochief
resident, Radiation Oncology Center, presented "Vascular radiotherapy for
restenosis" at the Society of
Cardiovascular and Interventional Radiology,
Orlando, Florida, March 14.

Lawler receives BJH award

Keith Fischer, MD, associate professor of radiology,
spoke on "Labeled antibodies: emphasis on prostate
cancer imaging" and "Tumor
imaging with Ir-111 labeled
somatostatin analogs" at the
Mississippi Society of
Nuclear Medicine's "Nuclear
Medicine Update," Jackson,
Mississippi, March 13 and
14.
Perry Grigsby, MD, MBA,
professor of radiology, as a
member of the American
Cancer Society's Traveling
Oncology Consultant Program, spoke on "Management of carcinoma of the
cervix," "Management of carcinoma of the endometrium,"
"NIH Consensus Conference
on carcinoma of the cervix,"
and "Management of carcinoma of the thyroid" at medical facilities in Van Nuys,
Long Beach, Los Angeles,
Burbank, Santa Monica,
Tarzana, and Loma Linda,
California, February 8 -12.
He presented "FDG-PET
evaluation of primary carcinoma of the cervix" at the
30th Annual Meeting of the
Society of Gynecologic
Oncologists, San Francisco,
California, March 20 - 24.

Robert Gropler, MD, associate professor of radiology i
and director of the cardiovascular imaging laboratory,
presented "Impairment of
myocardial blood flow alters
the myocardial stress-strain
relations in ischemic cardiomyopathy" at the American College of Cardiology
48th Annual Scientific Meet- ]
ing, New Orleans, Louisiana, J
March 7 -10.
Jay Heiken, MD, professor
of radiology, chief of abdominal radiology, and codirector of body computed
tomography, presented
"Hepatic contrast enhancement: a pharmacokinetic
approach" and "Contrast
enhancement for helical CT
of the liver and pancreas:
lessons and solutions from
computer modeling" at the
International Symposium:
Abdominal Imaging 1999,
Kumamoto, Japan, January
22 and 23. He presented the
Special Lecture, "CT evaluation of nontraumatic emergencies of the gastrointestinal tract," at the
Annual Meeting of the
Kyushu Society of Interventional Radiology, Kumamoto.
Japan, January 23. As visiting professor, Heiken spoke
on "A pharmacokinetic
approach to hepatic and
pancreatic enhancement for
helical CT: lessons from
computer modeling" at

Leo Lawler, MD, a third-year diagnostic radiology resident, received the Barnes-Jewish Hospital Foundation's Caring Spirit Award, which honors individuals
for their care, compassion, and service above and
beyond expectation. Lawler was nominated for the
award for his "beyond the typical" care and concern
for his patients as well as for his professionalism. The
mother of one patient cited that Lawler visited her son
morning and evening without fail and that after her
son's release from the hospital, "Doctor Lawler called
two to three times per week to just check in and see
how things were going."
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'okohama City University,
'okohama, Japan, January
26. He spoke on "A practical
approach to helical CT," "CT
^of the aorta: approach to
ipture and dissection,"
Characterization of hepatic
passes with CT and MRI,"
Ind "CT evaluation of nontraumatic GI emergencies"
at Sun Valley Imaging, sponsored by the University of
British Columbia, Sun Valley, Idaho, February 20 - 27.
[e presented "Imaging of
ie acute abdomen: abdominal aortic aneurysm" at the
Twenty-Eighth Annual Meetig and Postgraduate Course
[of the Society of Gastroin;estinal Radiologists, Palm
leach, Florida, March 21 26.

Eric Klein, MS, assistant
irofessor of radiology, as
vited lecturer, spoke on
"Multi-segmented electron
IMRT fields" at the Intensity
Modulated Electron Radioitherapy Symposium, Palo
fAlto, California, March 22.
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William McAlister, MD,
professor of radiology and
of pediatrics and chief of
pediatric radiology, as
invited lecturer, presented
"Alimentary tract emergencies in children" at the
Armand Brodeur Lecture,
sponsored by the City-Wide
Radiology Conferences,
Saint Louis University, St.
Louis, Missouri, January 12.
As invited lecturer, he presented "Imaging of sinusitis
in pediatrics" at the Larry
Davis Memorial Lecture,
Rosair Children's Hospital,
Louisville, Kentucky, Febru12.
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Elizabeth McFarland, MD,
assistant professor of radiology, presented "3D spiral CT
endoscopic applications" to
the St. Louis Society of Radiologists, St. Louis, Missouri,
January 19. She presented
"Spiral CT colonography:
technical considerations of
image acquisition and image
display" at the General Electric-Association of University Radiologists Research
Symposium, San Diego, California, March 12.
Robert McKinstry, MD,
PhD, instructor in radiology,
as invited lecturer, spoke on
"Diffusion tensor imaging" at
the University of Illinois,
Chicago Medical Center,
Department of Radiology,
January 20.
Jeff Michalski, MD, assistant professor of radiology,
presented "Radiation in
brain tumors" at the Brain
Tumor Support Network
meeting, sponsored by Missouri Baptist Medical Center, St. Louis, Missouri,
February 9. He spoke on
"3D CRT in prostate carcinoma," "Quality assurance
for 3D CRT clinical trials,"
and "3D conformal radiation
therapy for CNS and other
pediatric tumors: minimizing
toxicity and achieving a
cure," University of Montreal/McGill, Montreal,
Canada, March 3 and 4.

Biello Lecture
Jamshid Maddahi, MD, director of the Clinical PET Center
at the University of California, Los Angeles, was invited lecturer for the Thirteenth Annual Daniel R. Biello Memorial
Lecture on March 8. Dr. Maddahi spoke on "State-of-the-art
clinical applications of cardiovascular nuclear medicine:
diagnosis, prognosis, and myocardial viability." At left is
Barry Siegel, MD, director of the Division of Nuclear Medicine and coordinator of the Biello Lecture.
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LECTURES/
PRESENTATIONS
Continued from page 25
Tom Miller, MD, PhD, professor of radiology and of
electrical engineering, presented "Iterative reconstruction: its role in clinical
practice today and tomorrow" at the Society of
Nuclear Medicine Mid-Winter Symposium, Fort Lauderdale, Florida, Feburary 8
and 9.
Scott Mirowitz, MD, associate professor of radiology,
radiologist-in-chief at
Barnes Jewish Hospital
north, and codirector of
body magnetic resonance
imaging, as guest speaker,
spoke on "Diagnostic pitfalls
in abdominal MRI," "MRI
artifacts: challenges and
solutions," "MRI of the rotator cuff," and "Pitfalls in
knee MRI" at the Johns Hopkins School of Medicine MRI
Course, Marco Island,
Florida, March 13 and 14.

Eduardo Moros, PhD,
assistant professor of radiology, presented "Use of Ascan for penetration control
during dual-frequency ultrasound thermal therapy of
superficial tissues overlaying
bone and lung" at BiOS '99
International Symposium on
Biomedical Optics, in connection with Photonics West
99, sponsored by The International Society for Optical
Engineering, San Jose, California, January 23 - 29.
Vamsidhar Narra, MD,
instructor in radiology,
spoke on "Vascular MRA" at
the Vascular Surgery/Interventional Radiology Grand
Rounds, Washington University, St. Louis, Missouri, January 25. He presented "MRI
of focal hepatic lesions,"
"MRI of female pelvis," "3D
contrast enhanced MR

Vo receives academic
fellowship
Katie Vo, MD, a fellow in neuroradiology, is one of
only four radiology investigators nationwide to
receive a 1999 GE-AUR Radiology Research Academic
Fellowship. The award was presented for her
research on "Interventions to improve physician performance in interpreting cranial computed tomography scans of acute ischemic stroke patients."
The two-year fellowship provides a $50,000
annual stipend and is sponsored by the Association of
University Radiologists and General Electric Medical
Systems, a leading supplier of medical diagnostic
imaging technology. GE-AUR fellowships encourage
young investigators to pursue careers in radiology
research by allowing them to devote a substantial
amount of time to scientific projects in health outcomes, technology assessment, and related areas.
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angiography," and "MR
cholangiopancreatography"
at the Eastern Virginia Medical School, Norfolk, February 11 and 12.
Carlos Perez, MD, professor of radiology and director
of the Radiation Oncology
Center, spoke on "Threedimensional conformal radiation therapy and hormone
therapy in localized carcinoma of the prostate" at the
First Annual Palm Beach
Cancer Symposium, Palm
Beach, Florida, February 4 7. He presented "Radiation
therapy in the management
of carcinoma of the uterine
cervix" at the Cleveland
Clinic, Cleveland, Ohio, February 26.
James Purdy, PhD, professor of radiology, associate
director of the Radiation
Oncology Center, and chief
of radiation oncology
physics, as a faculty member, presented "3-D treatment planning and
conformal therapy" and
"Quality assurance for 3-D
conformal therapy" at the
Intensity Modulated Radiation Therapy Meeting, Rome,
Italy, February 18 - 22. As
invited speaker, he spoke on
"3-D treatment planning and
conformal therapy: problems and pitfalls" at the University of Wisconsin,
Madison, March 22.

Marcus Raichle, MD, pro
fessor of radiology and of
neurology and neurobiology ,
and codirector of the Divi- '
sion of Radiological Sciences, presented "The
neural correlates of consciousness" at the Salk Institute, San Diego, California,
Feburary 1. He spoke on
"Recent advances in neuroimaging" at Hypoxia 99,
Jasper, Alberta, Canada,
March 1.
Joseph Roti Roti, PhD,
professor of radiology, associate director of the Radiation Oncology Center, and
chief of cancer biology, presented "Nuclear matrix-DNA
interactions and the sensitivity of mammalian cells to
ionizing radiation" and "Subcellular localization of DNA
damage and repair: How
close can we look?" at the
Cellular Localization of
Repair and Effects of Bound
Proteins Session, The Gordon Conference, Ventura,
California, February 7 -12.
Stuart Sagel, MD, professor of radiology, chief of
chest radiology, and codirector of body computed
tomography, spoke on "Helical CT in the thorax," "CT
angiography for pulmonary
embolism," "Digital chesi
radiography," "HRCT of the
pulmonary parenchyma,"
"CT of focal lung lesions,
"CT: anatomic variations
and pitfalls in the thorax,
and "CT in bronchogenic
carcinoma" at the Intern;
tional Radiology Symposium, Sydney, Australia,
March 22 - 28.
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Barry Siegel, MD, profesMor of radiology and of medi■pne and director of the
Division of Nuclear MediKine, spoke on "New technologies—PET scanning in
_he staging of thoracic maligaancies" and "PET to assess
tie biology of thoracic
tialignancies" at the 12th
nnual Meeting of General
horacic Surgical Club,
/larco Island, Florida, March
11 -14.

San Francisco Resident
Review Course, February 10.
She presented "Ultrasonography of the pediatric chest"
at the American Institute of
Medicine Annual Meeting,
San Antonio, Texas, March
14 and 15. As invited lecturer, Siegel spoke on "Ultrasonography of the acute
pediatric abdomen" at the
University of Texas Health
Science Center, San Antonio, March 15.

arilyn Siegel, MD, professor of radiology and of
)ediatrics, presented
Neonatal cranial sonograhy" at the Pacific Northest Ultrasound Society
:eeting, Seattle, Washingion, January 21. As visiting
est lecturer, she presented
Ultrasonography of pedi,tric abdominal masses" at
e University of Washing;on, Seattle, January 21.
liegel spoke on "Ultrasonography of the acute abdomen
i children" at the Arkansas
onographer's Society,
'ayetteville, January 30. As
the invited Hooshang Taybi
honorary Lecturer, she preented "Practical applicaons of MR imaging in the
fpediatric patient" at Children's Oakland Hospital,
Oakland, California, February 9. Siegel spoke on
"Neonatal pulmonary disease" and "Genitourinary
anomalies and infections" at
the University of California,

Douglas Spitz, PhD, assistant professor of radiology,
spoke on "Glucose deprivation-induced oxidative stress
in human tumor cells" at the
Graduate Center for Toxicology Research Seminar, University of Kentucky,
Lexington, January 25 and
26; at the Department of
Radiation Oncology
Research Seminar, University of Pennsylvania,
Philadelphia, February 10
and 11; and at the Society of
Toxicology 38th Annual
Meeting, New Orleans,
Louisiana, March 15 -18.
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Match Day results announced
In June, 15 physicians will begin their first year of
training in the Institute's Diagnostic Radiology Residency Program. The results were announced on the
annual Match Day when senior medical students in
the United States learn which residency programs
they will enter in the upcoming academic year. Of the
new MIR trainees, three received medical degrees
from Duke University, two from Washington University, two from the University of Wisconsin, and one
each from Georgetown, Emory, Johns Hopkins, Yale,
Dartmouth, New York University, Boston University,
and the University of Missouri-Columbia.

Todd Wasserman, MD,
professor of radiology, presented "Protection of normal
tissue from toxicity" (an
educational program sponsored by The Institute for
Continuing Healthcare Education and supported by
MediCom of Princeton, Inc.
and Alza Pharmaceuticals),
St. Louis, Missouri, February
24. He presented "Combined chemotherapy and
radiotherapy for Hodgkin's
disease" and "Combined
chemotherapy and radiotherapy for non-Hodgkin's
lymphoma" to the Texas
Radiology Society, Dallas,
April 9.
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SYMPOSIA
In this section ofFYI, only those faculty and staff who have
MIR appointments are listed.

MEDICAL IMAGING 1999
Sponsored by The International Society for Optical
Engineering (SPIE)
San Diego, California
February 20 - 26, 1999
James Blaine, DSc, technical conference cochair,
"PACS design and evaluation: engineering and clinical issues."
Gilbert Jost, MD, panel
member, PACS Keynote Session, "PACS: now or never."
WORKSHOP
Gilbert Jost, MD, instructor, "IHE: the path to
demonstrating integration."
SCIENTIFIC SESSIONS
Elizabeth McFarland,
MD; Jay Heiken, MD;
Dennis Balfe, MD; Daniel
Hirselj, BS; Thomas Pilgram, PhD, "Spiral CT
colography (virtual
colonoscopy): multiobserver
study of different image display techniques compared to
colonoscopy."
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Elizabeth McFarland, MD,
"Colon unraveling based on
electrical field—recent
progress and further work."
Bruce Whiting, PhD; Elizabeth McFarland, MD;
Casey Dellabarca, BS;
Barry Brunsden, "Study of
CT artifacts in virtual
colonoscopy."
Bruce Whiting, PhD;
Richard Slone, MD;
Edward Muka, MSE,
"Dynamic viewing protocols
for diagnostic image
evaluation."
Bruce Whiting, PhD, "Statistically lossless image compression for CR and DR."
POSTER SESSIONS
Edward Muka, MSE;
Bruce Whiting, PhD, "The
veiling glare point-spread
function of medical imaging
monitors."

Edward Muka, MSE;
Bruce Whiting, PhD,
"Deploying CRT soft-copy
displays in medical imaging
systems: a discussion of
basic issues."

NATIONAL AMERICAN
CHEMICAL SOCIETY
217th Annual Meeting
Anaheim, California
March 21-25, 1999
Carolyn Anderson, PhD,
co-organizer, Bioconjugate
Chemistry in Nuclear Medicine Symposium.
SCIENTIFIC SESSIONS
Carolyn Anderson, PhD;
Laura Bass, PhD; Margaret Lanahan, MS,
"Metabolism of radiometallabeled octreotide analogs."
David Reichert, PhD;
Michael Welch, PhD, "Conformational analysis of
octreotide and indium
bifunctional chelate
conjugates."
Michael Lewis, PhD; Carolyn Anderson, PhD, "Evaluation of copper-64-labeled
anti-colorectal carcinoma
monoclonal antibody conjugate TETA-1A3."

MALLINCKRODT INSTITUTE OF RADII

David Gius, MD, PhD, instructor in radiology,
was selected as the 1998 Radiation Oncology Teacher of the Year. The Teacher of the
Year presentation is made annually in December
to honor the Institute faculty member who
makes a significant contribution to resident education during the academic year. Radiation
oncology residents select the award recipient
through a nomination and voting process.
Gius joined the faculty in 1997 after completing three years of training in radiation oncology at the Institute, including one year as an
American Society for Therapeutic Radiology and
Oncology Fellow. His medical and research
background is extensive and impressive: medical degree from the Stritch School of Medicine
at Loyola University of Chicago, doctoral degree
from the University of Chicago, postdoctoral fellowships in molecular genetics and cell biology
and in radiation and cellular oncology, a transitional internship at the the University of
Chicago, and one year of residency at the University of Michigan Medical Center. Gius currently has a lab in the Radiation Oncology
Center's cancer biology section where he is
investigating the events that activate and repress
cell division and growth.
Since the award's inception in 1989, the following faculty have been selected as teacher of
the year: (1989) Susan Shapiro, MD; (1990) Carlos Perez, MD; (1991 and 1995) Perry Grigsby,
MD; (1992) Jeff Michalski, MD; (1993) RusseU
Gerber, MS; (1994) Mary Graham, MD; (1996)
James Purdy, PhD; and (1997) Marie Taylor, MD.
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